{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:10:51Z","timestamp":1769926251952,"version":"3.49.0"},"reference-count":18,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Orbit"],"published-print":{"date-parts":[[2018,9,3]]},"DOI":"10.1080\/01676830.2017.1423349","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T21:34:10Z","timestamp":1517348050000},"page":"381-384","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Complete ophthalmoplegia in Ipilmumab and Nivolumab combination treatment for metastatic melanoma"],"prefix":"10.1080","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7998-2841","authenticated-orcid":false,"given":"Reem","family":"Alnabulsi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsen","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"DeAngelis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.565"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.3109\/01676830.2014.949792"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000178913.41256.06"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0499"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31828957c3"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1097\/01.cmr.0000399475.01484.56"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0905750"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e3181ef72a1"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0833"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104621"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412082"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70076-8"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0219-0"},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"Sznol M, Kluger HM, Callahan MK, et al. Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO 4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL). J Clin Oncol. 2014;32(5s):LBA9003. https:\/\/meetinglibrary.asco.org\/record\/92086\/abstract","DOI":"10.1093\/annonc\/mdu344.1"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414428"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302369"}],"container-title":["Orbit"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01676830.2017.1423349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T22:48:25Z","timestamp":1599259705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01676830.2017.1423349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9,3]]}},"alternative-id":["10.1080\/01676830.2017.1423349"],"URL":"https:\/\/doi.org\/10.1080\/01676830.2017.1423349","relation":{},"ISSN":["0167-6830","1744-5108"],"issn-type":[{"value":"0167-6830","type":"print"},{"value":"1744-5108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iorb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iorb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-05-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}